Philips and Diagnostics Development win European Union 'Horizon Prize - Better Use of Antibiotics'
Royal Philips (NYSE: PHG, AEX: PHIA), a leader in HealthTech, and Diagnostics Development, a P&M Venge company spin-off from Uppsala University (Sweden), have demonstrated a proof-of-concept for the rapid and reliable detection of bacterial infection. The test is based on Philips' Minicare I-20 handheld diagnostics platform and detects the human neutrophil lipocalin (HNL) biomarker in a single 'finger-prick' drop of blood. 
Carestream has signed its first full Clinical Collaboration Platform (CCP) contract with the Ikazia Hospital in Rotterdam, the Netherlands. This milestone agreement is for a period of five years, and is in addition to the PACS Cloud contract already in place with the hospital. 
Siemens Healthineers has been commissioned to take over the clinical laboratory service operations for two new hospitals in Turkey built and operated as Public Private Partnership (PPP) of DiA Holding and Turkish Ministry of Health. The five-year contract grants a minimum of close to 30 million Euros* in revenues. 
Red Hat, Inc. (NYSE: RHT), the world's leading provider of open source solutions, has announced that the European Bioinformatics Institute (EMBL-EBI), part of the European Molecular Biology Laboratory, is using Red Hat OpenStack Platform to deliver the scale and flexibility required to drive its Embassy Cloud project. 
Solution Match is one of the services offered by the EU-funded initiative eHealth Hub, intending to promote and boost up commercialization. The eHealth Hub aims to provide long-term support to the eHealth ecosystem stakeholders and addresses key challenges facing European SMEs in this space.